UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity

Muscle & nerve, 2008-04, Vol.37 (4), p.473-476

2008

Volltextzugriff (PDF)

Myasthenia gravis activities of daily living profile

Neurology, 1999-04, Vol.52 (7), p.1487-1487

1999

Volltextzugriff (PDF)

Autonomic nerve function in adult patients with cyclic vomiting syndrome

Neurogastroenterology and motility, 2011-05, Vol.23 (5), p.439-443

2011

Volltextzugriff (PDF)

A pilot study to measure upper extremity H-reflexes following neuromuscular electrical stimulation therapy after stroke

Neuroscience letters, 2013-02, Vol.535, p.1-6

2013

Volltextzugriff (PDF)

Pilot trial of etanercept in the treatment of inclusion-body myositis

Neurology, 2006-01, Vol.66 (2 Suppl 1), p.S123

2006

Volltextzugriff (PDF)

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial

JAMA neurology, 2021-01, Vol.78 (1), p.68

2021

Volltextzugriff (PDF)

48. Statin-associated autoimmune necrotizing myopathy

Clinical neurophysiology, 2012-06, Vol.123 (6), p.e30-e30

2012

Volltextzugriff (PDF)

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitat

Arthritis care & research (2010), 2011-11, Vol.63 (S11), p.S118-S157

2011

Volltextzugriff (PDF)

LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A164-A164

2013

Volltextzugriff (PDF)

Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations

Neurology, 2005-05, Vol.64 (9), p.1638-1640

2005

Volltextzugriff (PDF)

P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)

Neuromuscular disorders : NMD, 2011, Vol.21, p.S27-S27

2011

Volltextzugriff (PDF)

542P INSPIRE-IBM: an NIH-funded, two-year, multicenter, observational study in inclusion body myositis (IBM)-an update

Neuromuscular disorders : NMD, 2024-10, Vol.43, p.104441, Article 104441.133

2024

Volltextzugriff (PDF)

541P Comparative evaluation of pulmonary function tests and self-reported respiratory function in inclusion body myositis based on NT5c1A antibody serology status

Neuromuscular disorders : NMD, 2024-10, Vol.43, p.104441, Article 104441.132

2024

Volltextzugriff (PDF)

O04 Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial

Neuromuscular disorders : NMD, 2012-03, Vol.22, p.S4-S4

2012

Volltextzugriff (PDF)

Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis

Neurology, 1998-07, Vol.51 (1), p.110-113

1998

Volltextzugriff (PDF)

The natural history of amyotrophic lateral sclerosis

Neurology, 1993-07, Vol.43 (7), p.1316-1316

1993

Volltextzugriff (PDF)

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Annals of neurology, 2009-08, Vol.66 (2), p.235-244

2009

Volltextzugriff (PDF)

Patient Assisted Intervention for Neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS) (P1.435)

Neurology, 2018, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Essai d'écologie territoriale : L'exemple d'Aussois en Savoie

Nicolas Buclet

2015

Volltextzugriff (PDF)

O.33Subcutaneous immunoglobulin in myasthenia gravis: results of a North American open label study

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S125-S125

2019

Volltextzugriff (PDF)

Du transfert culturel au métissage : Concepts, acteurs, pratiques

2015

Volltextzugriff (PDF)

P.02Phase 2/3 study of Arimoclomol in sporadic inclusion body myositis: study design

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S41-S42

2019

Volltextzugriff (PDF)

Challenges in the identification of cobalamin-deficiency polyneuropathy

Archives of neurology (Chicago), 2003-09, Vol.60 (9), p.1296

2003

Volltextzugriff (PDF)

A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2015-08, Vol.16 (5-6), p.345-352

2015

Volltextzugriff (PDF)

Reliability Testing of the Quantitative Myasthenia Gravis Score

Annals of the New York Academy of Sciences, 1998-05, Vol.841 (1), p.769-772

1998

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(109)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(119)
Französisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(66)
Humans
(57)
Female
(46)
Male
(43)
Biological And Medical Sciences
(35)
Neurosciences & Neurology
(34)
Clinical Neurology
(33)
Medical Sciences
(32)
Middle Aged
(30)
Adult
(25)
Neurology
(25)
Aged
(19)
Animals
(19)
Immunology
(17)
Mice
(16)
Neurosciences
(16)
Humanities And Social Sciences
(14)
Treatment Outcome
(12)
Diseases Of Striated Muscles. Neuromuscular Diseases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity

Myasthenia gravis activities of daily living profile

Autonomic nerve function in adult patients with cyclic vomiting syndrome

A pilot study to measure upper extremity H-reflexes following neuromuscular electrical stimulation therapy after stroke

Pilot trial of etanercept in the treatment of inclusion-body myositis

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial

48. Statin-associated autoimmune necrotizing myopathy

LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial

Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations

P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)

542P INSPIRE-IBM: an NIH-funded, two-year, multicenter, observational study in inclusion body myositis (IBM)-an update

541P Comparative evaluation of pulmonary function tests and self-reported respiratory function in inclusion body myositis based on NT5c1A antibody serology status

O04 Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial

Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis

The natural history of amyotrophic lateral sclerosis

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Patient Assisted Intervention for Neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS) (P1.435)

Essai d'écologie territoriale : L'exemple d'Aussois en Savoie

O.33Subcutaneous immunoglobulin in myasthenia gravis: results of a North American open label study

Du transfert culturel au métissage : Concepts, acteurs, pratiques

P.02Phase 2/3 study of Arimoclomol in sporadic inclusion body myositis: study design

Challenges in the identification of cobalamin-deficiency polyneuropathy

A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement

Reliability Testing of the Quantitative Myasthenia Gravis Score

Suchergebnisse filtern